Clinical trial
Pulmonary Embolism Removal With the AngioJet 6F Ultra SystEm (PERFUSE)
NCT01638468 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pulmonary Embolism Removal With the AngioJet 6F Ultra SystEm (PERFUSE)
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- January 31, 2013
- Completion date
- January 31, 2016
- Enrollment
- 7 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.